Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts
- PMID: 18562564
- PMCID: PMC2519317
- DOI: 10.1128/CVI.00058-08
Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts
Abstract
Immunizations with Plasmodium falciparum MSP1-42 or MSP1-19 induce antibodies that inhibit parasites in vitro, which correlates with in vivo protective immunity by vaccination. We previously showed that several adjuvant formulations can induce anti-MSP1-19 antibodies in interleukin-6, intercellular adhesion molecule 1, CD80, and CD86 knockout (KO) mice and at levels similar to those obtained in the healthy uninfected hosts. Here, we determine whether these immune gene KOs or the immunopotentiating activities of the adjuvants have a more important influence on the induction of parasite-inhibitory anti-MSP1-19 antibodies. Results showed that the biological activities of the anti-MSP1-19 antibodies induced by these adjuvants were not affected by the immune gene KOs. All adjuvant formulations that induced significant inhibitory antibody responses (i.e., >50% inhibition of parasite growth) contained monophosphoryl lipid A (MPL) in emulsion carriers, whereas MPL or emulsion carriers alone were ineffective. The ability to retain vaccine efficacy by the MSP1-19 and adjuvant formulations in the altered immunological background is a valuable and significant attribute in light of many instances of skewed immune status in the targeted vaccine populations.
Figures

Similar articles
-
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05. Infect Immun. 2006. PMID: 16861644 Free PMC article.
-
Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.Infect Immun. 1998 Nov;66(11):5329-36. doi: 10.1128/IAI.66.11.5329-5336.1998. Infect Immun. 1998. PMID: 9784540 Free PMC article.
-
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.Malar J. 2013 Jan 23;12:29. doi: 10.1186/1475-2875-12-29. Malar J. 2013. PMID: 23342996 Free PMC article. Clinical Trial.
-
Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice.Infect Immun. 2019 May 21;87(6):e00911-18. doi: 10.1128/IAI.00911-18. Print 2019 Jun. Infect Immun. 2019. PMID: 30936155 Free PMC article.
-
The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria.Parasitology. 2009 Oct;136(12):1445-56. doi: 10.1017/S0031182009990515. Epub 2009 Jul 23. Parasitology. 2009. PMID: 19627632 Review.
Cited by
-
Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response.PLoS One. 2010 Nov 3;5(11):e15391. doi: 10.1371/journal.pone.0015391. PLoS One. 2010. PMID: 21082025 Free PMC article.
-
Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.Med Microbiol Immunol. 2018 Apr;207(2):151-166. doi: 10.1007/s00430-018-0535-4. Epub 2018 Feb 3. Med Microbiol Immunol. 2018. PMID: 29397427
-
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.PLoS One. 2011;6(9):e24782. doi: 10.1371/journal.pone.0024782. Epub 2011 Sep 13. PLoS One. 2011. PMID: 21931852 Free PMC article.
-
Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies.Vaccine. 2011 Nov 8;29(48):8898-908. doi: 10.1016/j.vaccine.2011.09.070. Epub 2011 Sep 28. Vaccine. 2011. PMID: 21963870 Free PMC article.
-
Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.FASEB J. 2013 Mar;27(3):1153-66. doi: 10.1096/fj.12-218362. Epub 2012 Nov 29. FASEB J. 2013. PMID: 23195035 Free PMC article.
References
-
- Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424:329-334. - PubMed
-
- Angov, E., E. S. Bergman-Leitner, E. H. Duncan, A. Brent-Kirk, M. McCasland, R. Mease, L. Soisson, M.-A. Demoitie, B. R. Ogutu, D. G. Heppner, and J. A. Lyon. 2007. Measurement of antibody fine specificities induced by malaria vaccine FMP1/ASO2A from a pediatric phase 2B trial in western Kenya. Am. J. Trop. Med. Hyg., vol. 77, issue 5 (Suppl.), abstr. 12.
-
- Brady, C. P., R. L. Shimp, A. P. Miles, M. Whitmore, and A. W. Stowers. 2001. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Protein Expr. Purif. 23:468-475. - PubMed
-
- Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. Hut. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261. - PMC - PubMed
-
- Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. Hui. 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials